Effects of Single and Multiple Flavonoids on BCRP-Mediated Accumulation, Cytotoxicity and Transport of Mitoxantrone In Vitro

被引:23
作者
An, Guohua [1 ]
Morris, Marilyn E. [1 ]
机构
[1] SUNY Buffalo, Dept Pharmaceut Sci, Sch Pharm & Pharmaceut Sci, Buffalo, NY 14260 USA
关键词
ABCG2; cytotoxicity; flavonoids; mitoxantrone; multidrug resistance; CANCER RESISTANCE PROTEIN; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; (ABCG2)-MEDIATED TRANSPORT; DIETARY FLAVONOIDS; DRUG TRANSPORT; MDCK CELLS; EXPRESSION; BCRP/ABCG2; ABCG2;
D O I
10.1007/s11095-010-0108-8
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
The objective of our study was to investigate the effect of single and multiple flavonoids on the accumulation and cytotoxicity of mitoxantrone in BCRP-overexpressing breast cancer cells and on the transport of mitoxantrone in BCRP-expressing normal cells. The effect of flavonoids on mitoxantrone accumulation and cytotoxicity was studied in the human breast cancer MCF-7 MX100 cell line. Mitoxantrone transport in the presence of flavonoids was studied in human and murine BCRP-transfected MDCK cell lines, and mitoxantrone concentrations were determined by HPLC. Our results demonstrated that multiple flavonoid combinations act additively and exhibit strong BCRP inhibition for increasing mitoxantrone accumulation in breast cancer cells. Kaempferide, biochanin A, 5,7-dimethoxyflavone, and 8-methylflavone greatly increased the cytotoxicity of mitoxantrone in BCRP-overexpressing breast cancer cells. Additionally, the basolateral-to-apical membrane-directed transport of mitoxantrone in murine Bcrp1- and human BCRP-expressing MDCK cells, in the presence of 2.5 A mu M of these flavonoids, was also significantly decreased. The results indicate that flavonoids are potent BCRP inhibitors and that they exert additive effects when used in combination. Flavonoids demonstrate MDR-reversing effects, but also may influence the disposition of mitoxantrone and cause pharmacokinetic interactions.
引用
收藏
页码:1296 / 1308
页数:13
相关论文
共 43 条
[1]
Inhibitors of cancer cell multidrug resistance mediated by breast cancer resistance protein (BCRP/ABCG2) [J].
Ahmed-Belkacem, Abdelhakim ;
Pozza, Alexandre ;
Macalou, Sira ;
Perez-Victoria, Jose M. ;
Boumendjel, Ahcene ;
Di Pietro, Attilio .
ANTI-CANCER DRUGS, 2006, 17 (03) :239-243
[2]
CORRELATIONS BETWEEN METHODS FOR MEASUREMENT OF SYNERGY [J].
BERENBAUM, MC .
JOURNAL OF INFECTIOUS DISEASES, 1980, 142 (03) :476-478
[3]
Cellular pharmacology of mitoxantrone in p-glycoprotein-positive and -negative human myeloid leukemic cell lines [J].
Consoli, U ;
Van, NT ;
Neamati, N ;
Mahadevia, R ;
Beran, M ;
Zhao, S ;
Andreeff, M .
LEUKEMIA, 1997, 11 (12) :2066-2074
[4]
Diah SK, 2001, CANCER RES, V61, P5461
[5]
Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material [J].
Diestra, JE ;
Scheffer, GL ;
Català, I ;
Maleipaad, M ;
Schellens, JHM ;
Scheper, RJ ;
Germà-Lluch, JR ;
Izquierdo, MA .
JOURNAL OF PATHOLOGY, 2002, 198 (02) :213-219
[6]
A multidrug resistance transporter from human MCF-7 breast cancer cells [J].
Doyle, LA ;
Yang, WD ;
Abruzzo, LV ;
Krogmann, T ;
Gao, YM ;
Rishi, AK ;
Ross, DD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15665-15670
[7]
Phytochemicals induce breast cancer resistance protein in Caco-2 cells and enhance the transport of benzo[a]pyrene-3-sulfate [J].
Ebert, Bettina ;
Seidel, Albrecht ;
Lampen, Alfonso .
TOXICOLOGICAL SCIENCES, 2007, 96 (02) :227-236
[8]
PHARMACOKINETICS AND METABOLISM OF MITOXANTRONE - A REVIEW [J].
EHNINGER, G ;
SCHULER, U ;
PROKSCH, B ;
ZELLER, KP ;
BLANZ, J .
CLINICAL PHARMACOKINETICS, 1990, 18 (05) :365-380
[9]
Involvement of breast cancer resistance protein (BCRP/ABCG2) in the biliary excretion and intestinal efflux of troglitazone sulfate, the major metabolite of troglitazone with a cholestatic effect [J].
Enokizono, Junichi ;
Kusuhara, Hiroyuki ;
Sugiyama, Yuichi .
DRUG METABOLISM AND DISPOSITION, 2007, 35 (02) :209-214
[10]
Interactions of polyphenolic compounds with drug disposition and metabolism [J].
Galli, Francesco .
CURRENT DRUG METABOLISM, 2007, 8 (08) :830-838